| Literature DB >> 28751980 |
Yanli Liu1,2, Yi Dong3, Kanxing Zhao1,3,4,5.
Abstract
PURPOSE: To date, the topic of amblyopic changes remains controversial. Therefore, a systematic review and meta-analysis were carried out to evaluate choroidal changes in unilateral amblyopia.Entities:
Year: 2017 PMID: 28751980 PMCID: PMC5494565 DOI: 10.1155/2017/2915261
Source DB: PubMed Journal: J Ophthalmol ISSN: 2090-004X Impact factor: 1.909
Figure 1PRISMA flow diagram of studies included in the meta-analysis.
Characteristics of the 11 studies included in the analysis.
| Study | Location | Amblyopia | Sample size | Age (years) | Type of OCT | AHRQ score | ||
|---|---|---|---|---|---|---|---|---|
| Case | Control | Case | Control | |||||
| Guo et al. [ | China | A | 13 | — | 9.6 ± 2.45 | — | Spectralis OCT | 8 |
| S | 9 | |||||||
| Celik et al. [ | Turkey | A | 43 | — | 24.8 ± 7.4 | — | Cirrus HD-OCT | 8 |
| Aygit et al. [ | Turkey | A | 40 | 40 | 7.9 ± 2.6 | 8.4 ± 2.6 | Spectralis OCT | 9 |
| S | 40 | 9.0 ± 3.7 | ||||||
| Tenlik et al. [ | Turkey | A | 53 | 53 | 17.8 ± 11.0 | 17.7 ± 11.0 | Cirrus HD-OCT | 9 |
| Kantarci et al. [ | Turkey | A | 54 | 52 | 39.5 ± 10.4 | 38.5 ± 10.2 | RS-3000 OCT | 7 |
| Xu et al. [ | China | A | 21 | 22 | 7.86 ± 1.85 | 7.82 ± 1.10 | Spectralis OCT | 8 |
| S | 16 | 9.13 ± 2.00 | ||||||
| Mori et al. [ | Japan | A | 24 | 12 | 4.5 ± 1.4 | Matched | Spectralis OCT | 9 |
| Nishi et al. [ | Japan | A | 25 | 20 | 6.7 ± 1.9 | 6.6 ± 2.2 | Spectralis OCT | 9 |
| Öner et al. [ | Turkey | A | 33 | 42 | 10.7 ± 3.3 | 11.2 ± 3.3 | Cirrus HD-OCT | 8 |
| Karaca et al. [ | Turkey | A | 40 | 40 | 8.82 ± 3.6 | 9.45 ± 2.25 | Spectralis OCT | 8 |
| Kara et al. [ | Turkey | A | 17 | 38 | 10.00 ± 2.87 | 11.84 ± 3.17 | Spectralis OCT | 8 |
S: strabismic amblyopia; A: anisometropic amblyopia; AL: axial length; AHRQ: Agency for Healthcare Research and Quality.
Pooled results comparing SFCT in the amblyopic eye with the fellow eye and the normal control eye.
| Groups | AL/ | WMD (95% CI) |
| Test for heterogeneity | Egger's test ( | Begg's test ( |
|---|---|---|---|---|---|---|
| A versus F | All/10 | 49.24 (30.22–68.27) |
|
| 0.291 | 0.622 |
| Matched/4 | 57.69 (36.71–78.68) |
|
| 0.410 | 0.497 | |
| Unmatched/6 | 44.36 (19.19–69.53) |
|
| 0.175 | 0.348 | |
|
| ||||||
| A versus C | All/9 | 54.51 (32.17–76.85) |
|
| 0.093 | 0.427 |
| Matched/4 | 55.65 (19.37–91.92) |
|
| 0.851 | 0.497 | |
| Unmatched/5 | 53.77 (22.67–84.86) |
|
| 0.195 | 0.624 | |
|
| ||||||
| F versus C | All/8 | 13.80 (−1.16, 28.77) |
|
| 0.340 | 1.000 |
SFCT: subfoveal choroidal thickness; AL: axial length; WMD: weighted mean differences; CI: confidence interval; A: amblyopia; C: control; F: fellow.
Figure 2Pooled estimates for all studies comparing SFCT in the amblyopic eye with the fellow eye and the normal control eyes. (a) The amblyopic eye versus the fellow eye. (b) The amblyopic eye versus the control eye. (c) Fellow versus control. (d) Amblyopic type subgroup analysis when the amblyopic eye is compared to the fellow eye. The SFCT of the amblyopic eye was thicker than that of both the fellow and the control eyes, both in the overall and in the subgroups (AL matched/not). The results for the amblyopic type subgroup analysis were the same as for the axial length subgroup analysis. Note: weights are from random effects analysis.
Pooled estimates of all studies comparing other positions in the amblyopic eye with the fellow and normal eyes.
| Group | Position/ | WMD (random) (95% CI) |
| Test for heterogeneity | Egger's test ( | Begg's test ( |
|---|---|---|---|---|---|---|
| A versus F | T 0.5 mm/2 | 40.14 (15.00–65.27) |
|
| — | 0.317 |
| N 0.5 mm/2 | 46.38 (20.35–72.42) |
|
| — | 0.317 | |
| T 1.0 mm/6 | 20.83 (11.01–30.64) |
|
| 0.289 | 0.188 | |
| N 1.0 mm/6 | 36.95 (20.52–53.38) |
|
| 0.020 | 0.851 | |
| S 1.0 mm/2 | 31.66 (12.50–50.83) |
|
| — | 0.317 | |
| I 1.0 mm/2 | 31.34 (13.92–48.76) |
|
| — | 0.317 | |
| T 2.0 mm/2 | 7.71 (−43.79–59.21) |
|
| — | 0.317 | |
| N 2.0 mm/2 | 45.63 (21.18–70.09) |
|
| — | 0.317 | |
| T 3.0 mm/2 | 17.46 (2.59–32.33) |
|
| — | 0.317 | |
| N 3.0 mm/2 | 26.81 (13.68–39.93) |
|
| — | 0.317 | |
|
| ||||||
| A versus C | T 0.5 mm/2 | 74.12 (16.74–131.50) |
|
| — | 0.317 |
| N 0.5 mm/2 | 30.71 (−7.14–74.56) |
|
| — | 0.317 | |
| T 1.0 mm/6 | 29.01 (15.01–49.00) |
|
| 0.175 | 0.851 | |
| N 1.0 mm/6 | 55.05 (28.60–81.50) |
|
| 0.478 | 0.573 | |
| S 1.0 mm/2 | 50.92 (−6.18–108.03) |
|
| — | 0.317 | |
| I 1.0 mm/2 | 47.42 (3.89–90.94) |
|
| — | 0.317 | |
| T 2.0 mm/2 | 24.26 (−1.59–50.11) |
|
| — | 0.317 | |
| N 2.0 mm/2 | 67.60 (3.77–91.43) |
|
| — | 0.317 | |
| T 3.0 mm/2 | 20.12 (10.06–30.17) |
|
| — | 0.317 | |
| N 3.0 mm/2 | 27.01 (13.65–40.38) |
|
| — | 0.317 | |
|
| ||||||
| F Vs C | T 0.5 mm/2 | 35.06 (−36.61–106.73) |
|
| — | 0.317 |
| N 0.5 mm/2 | −9.35 (−34.53–15.84) |
|
| — | 0.317 | |
| T 1.0 mm/6 | 5.86 (−12.10–23.81) |
|
| 0.917 | 0.851 | |
| N 1.0 mm/6 | 17.13 (−1.09–35.34) |
|
| 0.761 | 0.573 | |
| S 1.0 mm/2 | 19.54 (−33.19–72.28) |
|
| — | 0.317 | |
| I 1.0 mm/2 | 15.64 (−32.93–64.21) |
|
| — | 0.317 | |
| T 2.0 mm/2 | 16.26 (−13.02–45.54) |
|
| — | 0.317 | |
| N 2.0 mm/2 | 18.37 (−6.87–43.61) |
|
| — | 0.317 | |
| T 3.0 mm/2 | 4.75 (−3.41–12.91) |
|
| — | 0.317 | |
| N 3.0 mm/2 | 0.98 (−12.55–14.51) |
|
| — | 0.317 | |
T: temporal; N: nasal; S: superior; I: inferior; WMD: weighted mean differences; CI: confidence interval; A: amblyopia; C: control; F: fellow.
Figure 3Sensitivity analysis of meta-analysis. (a) The amblyopic eye versus the fellow eye. (b) The amblyopic eye versus the control eye. When one study is deleted at a time, the corresponding estimates do not change significantly.